Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Condition(s):Postpartum Preeclampsia; Hypertension in PregnancyLast Updated:June 1, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Postpartum Preeclampsia; Hypertension in PregnancyLast Updated:June 1, 2022Not yet recruiting
Condition(s):Preterm Labor Without Delivery; Pregnancy PretermLast Updated:September 15, 2022Recruiting
Condition(s):Threatened Preterm LaborLast Updated:December 8, 2023Recruiting
Condition(s):Postpartum Pregnancy-Induced Hypertension; Postpartum Preeclampsia; Pregnancy-Induced Hypertension in Postpartum; Hypertensive EmergencyLast Updated:March 18, 2024Not yet recruiting
Condition(s):Threatened Preterm LaborLast Updated:December 8, 2023Recruiting
Condition(s):Systolic Hypertension; Pregnancy Related; Diastolic Hypertension; Cardiac Output, Low; Cardiac Output, HighLast Updated:March 13, 2024Recruiting
Condition(s):Severe PreeclampsiaLast Updated:February 20, 2024Not yet recruiting
Condition(s):Epilepsy; Epilepsies, PartialLast Updated:November 16, 2022Recruiting
Condition(s):Obstetric Labor, PrematureLast Updated:August 11, 2020Not yet recruiting
Condition(s):Postpartum Complication; Maternal Hypertension; High Blood PressureLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.